Dermatology and Venereology, Volume 33, Issue 9Pages: 1619-1807, e310-e347 September 2019

---

Issue Information

Issue Information

Pages: 1619-1624 | First Published: 29 August 2019

EDITOR’S PICKS

Editor’s Picks

Pages: 1625 | First Published: 29 August 2019

EDITORIAL

JEADV on the road and in your pocket – recent developments in our Journal

J. Ring

Pages: 1626 | First Published: 29 August 2019

COMMENTARIES

Livedoid vasculopathy: how to diagnose and how to treat?

D. Lipsker

Pages: 1627-1628 | First Published: 29 August 2019

Linked article: C. Weishaupt et al. J Eur Acad Dermatol Venereol 2019; 33: 1784–1791. https://doi.org/10.1111/jdv.15639.

Atopic dermatitis and metabolic syndrome: lifestyle or systemic inflammation?

C. Vestergaard

Pages: 1629 | First Published: 29 August 2019

Linked article: G. Shalom et al. J Eur Acad Dermatol Venereol 2019; 33: 1762–1767. https://doi.org/10.1111/jdv.15642.

HISTORICAL PERSPECTIVES

Pioneers in Dermatology and Venereology: an interview with Prof. Lawrence C. Parish

L.C. Parish

Pages: 1630-1632 | First Published: 29 August 2019

GUIDELINES AND POSITION STATEMENTS

Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient‐Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa

P.V. Chernyshov, C.C. Zouboulis, L. Tomas‐Aragones, G.B. Jemec, A. Svensson, L. Manolache, T. Tzellos, F. Sampogna, N. Pustisek, H.H. van der Zee, S.E. Marron, S. Spillekom‐van Koulil, A. Bewley, D. Linder, D. Abeni, J.C. Szepietowski, M. Augustin, A.Y. Finlay

Pages: 1633-1643 | First Published: 29 April 2019

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period

C. Vestergaard, A. Wollenberg, S. Barbarot, S. Christen‐Zaech, M. Deleuran, P. Spuls, C. Flohr, M. Trzeciak, L. von Kobyletzki, J. Seneschal, C. Paul, T. Bieber, T. Werfel, R. Fölster‐Holst, U. Darsow, U. Gieler, Å. Svensson, M. Cork, J.‐F. Stalder, L. De Raeve, B. Kunz, D. Simon, P. Chernyshov, D. Hijnen, C. Gelmetti, J. Ring, A. Taieb, M. de Bruin‐Weller, J.P. Thyssen

Pages: 1644-1659 | First Published: 23 June 2019

REVIEW ARTICLES

Lipschütz genital ulcer revisited: is juvenile gangrenous vasculitis of the scrotum the male counterpart?

W. Chen, G. Plewig

Pages: 1660-1666 | First Published: 23 March 2019

Clinical visible signs of disease activity in vitiligo: a systematic review and meta‐analysis

N. van Geel, L. Grine, P. De Wispelaere, D. Mertens, C.A.C. Prinsen, R. Speeckaert

Pages: 1667-1675 | First Published: 26 May 2019

 Open Access

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis

J.J. Crowley, R.B. Warren, J.C. Cather

Pages: 1676-1684 | First Published: 03 May 2019

Review of autoimmune blistering diseases: the Pemphigoid diseases

B.S. Daniel, D.F. Murrell

Pages: 1685-1694 | First Published: 13 May 2019

ORIGINAL ARTICLES AND SHORT REPORTS ONCOLOGY

Low Drosha protein expression in cutaneous T‐cell lymphoma is associated with worse disease outcome

T. Gambichler, K. Salveridou, L. Schmitz, H.U. Käfferlein, T. Brüning, E. Stockfleth, M. Sand, K. Lang

Pages: 1695-1699 | First Published: 04 May 2019

Distinguishing melanocytic nevi from melanomas using static and dynamic infrared thermal imaging

C. Magalhaes, R. Vardasca, M. Rebelo, R. Valenca‐Filipe, M. Ribeiro, J. Mendes

Pages: 1700-1705 | First Published: 11 April 2019

 Open Access

Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology

O.T. Jones, L.C. Jurascheck, M. Utukuri, M.M. Pannebakker, J. Emery, F.M. Walter

Pages: 1706-1712 | First Published: 12 April 2019

Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study

M. Fradet, M. Negretto, E. Tournier, C. Laurent, P.A. Apoil, S. Evrard, Y. Degboe, V. Del Mas, L. Lamant, P. Dubreuil, M. Laroche, C. Mailhol, O. Hermine, C. Paul, C. Bulai Livideanu

Pages: 1713-1718 | First Published: 22 April 2019

Prolonged overall survival following metastasectomy in stage IV melanoma

M.L. Elias, S. Behbahani, S. Maddukuri, A.M. John, R.A. Schwartz, W.C. Lambert

Pages: 1719-1725 | First Published: 09 May 2019

PSORIASIS

Comparison of methods to estimate the affected body surface area and the dosage of topical treatments in psoriasis and atopic dermatitis: the advantage of a picture‐based tool

R. Speeckaert, I. Hoorens, S. Corthals, L. Delbaere, J. Lambert, T. Lesseliers, S. Mylle, K. Ongenae, S. De Schepper, L. De Smet, M. Speeckaert, N. van Geel

Pages: 1726-1732 | First Published: 05 June 2019

Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years

K. Reich, A. Blauvelt, A. Armstrong, R.G. Langley, A. de Vera, F. Kolbinger, S. Spindeldreher, M. Ren, G. Bruin

Pages: 1733-1741 | First Published: 22 April 2019

ALLERGY AND ECZEMA

Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole

S. Ständer, G. Yosipovitch, A.G. Bushmakin, J.C. Cappelleri, T. Luger, W.L. Tom, W.C. Ports, M.A. Zielinski, A.M. Tallman, H. Tan, R.A. Gerber

Pages: 1742-1746 | First Published: 27 May 2019

20 of 51 articles shown